Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?

Background. In Russia, the prevalence of diabetes continues to increase with the growing diabetes epidemic. In recent years, the paradigm of diabetes treatment has been changing, with patients increasingly becoming equal participants in the treatment process, through the introduction of sel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Larisa Dmitrievna Popovich, Marina Vladimirovna Shestakova, Elena Georgievna Potapchik, Alexander Yur'evich Mayorov, Olga Konstantinovna Vikulova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2017
Materias:	the burden of diabetes self-control economic benefits Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/823ef1d5fdd8408c8bec2fec5f1c48ef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:823ef1d5fdd8408c8bec2fec5f1c48ef
record_format	dspace
spelling	oai:doaj.org-article:823ef1d5fdd8408c8bec2fec5f1c48ef2021-11-14T09:00:21ZIs it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?2072-03512072-037810.14341/7077https://doaj.org/article/823ef1d5fdd8408c8bec2fec5f1c48ef2017-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8305https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background. In Russia, the prevalence of diabetes continues to increase with the growing diabetes epidemic. In recent years, the paradigm of diabetes treatment has been changing, with patients increasingly becoming equal participants in the treatment process, through the introduction of self-monitoring blood glucose (SMBG). Several clinical studies have demonstrated a positive relationship between SMBG and the decline of the epidemiological and economic burden of diabetes. At present, the procurement of public funds for SMBG is below the specified level in Russia. Aims. To investigate the potential macroeconomic benefits of public health resource allocation and the use of planned state investments to fund SMBG in insulin-treated diabetic patients. Materials and methods. This study was conducted with data from insulin-treated diabetic patients. The epidemiological burden of this cohort was determined by the following indicators: the number of patients and the incidence of complications resulting from diabetes, disability, mortality, age and sex. The economic benefits were evaluated by the implementation of two measures: (1) procurement of public funds for the purchase of means for SMBG in patients with insulin-treated diabetes and (2) the use of highly accurate blood glucose metres. To evaluate economic burden, the epidemiological burden was translated into monetary terms using cost-of-illness. Economic benefits were defined as reductions in economic burden. Results. The economic benefits of public-funded blood glucose test strips for insulin-treated diabetic patients exceeded the required additional investments for their purchase by 1.5 fold. A significant reduction in the inaccuracy of blood glucose metres from 20% to 10% may reduce the economic burden by 9.36 billion RUB. The combined state benefits from the implementation of both measures would significantly decrease the economic burden of diabetes to 29.2 billion RUB. Conclusions. Increased procurement of public funds for SMBG in insulin-treated diabetic patients would bring economic benefits that far exceed the required investments.Larisa Dmitrievna PopovichMarina Vladimirovna ShestakovaElena Georgievna PotapchikAlexander Yur'evich MayorovOlga Konstantinovna VikulovaEndocrinology Research Centrearticlethe burden of diabetesself-controleconomic benefitsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 2, Pp 108-118 (2017)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	the burden of diabetes self-control economic benefits Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	the burden of diabetes self-control economic benefits Nutritional diseases. Deficiency diseases RC620-627 Larisa Dmitrievna Popovich Marina Vladimirovna Shestakova Elena Georgievna Potapchik Alexander Yur'evich Mayorov Olga Konstantinovna Vikulova Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
description	Background. In Russia, the prevalence of diabetes continues to increase with the growing diabetes epidemic. In recent years, the paradigm of diabetes treatment has been changing, with patients increasingly becoming equal participants in the treatment process, through the introduction of self-monitoring blood glucose (SMBG). Several clinical studies have demonstrated a positive relationship between SMBG and the decline of the epidemiological and economic burden of diabetes. At present, the procurement of public funds for SMBG is below the specified level in Russia. Aims. To investigate the potential macroeconomic benefits of public health resource allocation and the use of planned state investments to fund SMBG in insulin-treated diabetic patients. Materials and methods. This study was conducted with data from insulin-treated diabetic patients. The epidemiological burden of this cohort was determined by the following indicators: the number of patients and the incidence of complications resulting from diabetes, disability, mortality, age and sex. The economic benefits were evaluated by the implementation of two measures: (1) procurement of public funds for the purchase of means for SMBG in patients with insulin-treated diabetes and (2) the use of highly accurate blood glucose metres. To evaluate economic burden, the epidemiological burden was translated into monetary terms using cost-of-illness. Economic benefits were defined as reductions in economic burden. Results. The economic benefits of public-funded blood glucose test strips for insulin-treated diabetic patients exceeded the required additional investments for their purchase by 1.5 fold. A significant reduction in the inaccuracy of blood glucose metres from 20% to 10% may reduce the economic burden by 9.36 billion RUB. The combined state benefits from the implementation of both measures would significantly decrease the economic burden of diabetes to 29.2 billion RUB. Conclusions. Increased procurement of public funds for SMBG in insulin-treated diabetic patients would bring economic benefits that far exceed the required investments.
format	article
author	Larisa Dmitrievna Popovich Marina Vladimirovna Shestakova Elena Georgievna Potapchik Alexander Yur'evich Mayorov Olga Konstantinovna Vikulova
author_facet	Larisa Dmitrievna Popovich Marina Vladimirovna Shestakova Elena Georgievna Potapchik Alexander Yur'evich Mayorov Olga Konstantinovna Vikulova
author_sort	Larisa Dmitrievna Popovich
title	Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
title_short	Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
title_full	Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
title_fullStr	Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
title_full_unstemmed	Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
title_sort	is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?
publisher	Endocrinology Research Centre
publishDate	2017
url	https://doaj.org/article/823ef1d5fdd8408c8bec2fec5f1c48ef
work_keys_str_mv	AT larisadmitrievnapopovich isitbeneficialtothestatetoprovideinsulintreateddiabeticpatientswithpublicfundsforselfmonitoringbloodglucose AT marinavladimirovnashestakova isitbeneficialtothestatetoprovideinsulintreateddiabeticpatientswithpublicfundsforselfmonitoringbloodglucose AT elenageorgievnapotapchik isitbeneficialtothestatetoprovideinsulintreateddiabeticpatientswithpublicfundsforselfmonitoringbloodglucose AT alexanderyurevichmayorov isitbeneficialtothestatetoprovideinsulintreateddiabeticpatientswithpublicfundsforselfmonitoringbloodglucose AT olgakonstantinovnavikulova isitbeneficialtothestatetoprovideinsulintreateddiabeticpatientswithpublicfundsforselfmonitoringbloodglucose
_version_	1718429541536366592

Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?

Ejemplares similares